Experimental Patch Provides Real-Time Feedback On Muscle Performance

An experimental wireless patch might help injured athletes better recover from muscle tears, sprains and strains, according to a new study.

The patch measures tissue stiffness by sending sound waves along the surface of the body and listening to the resulting vibrations, researchers said recently in the journal Science Advances.

Bladder Control Problems? There May Be An App For That

Having trouble with bladder control? There might be an app for that, researchers say.

Female veterans suffering from urinary incontinence received effective relief using a smartphone app called MyHealtheBladder, researchers reported Sept. 16 in JAMA Network Open.

The app delivered daily sessions over eight weeks, teaching th...

Pharma Payments Might Influence MS Drug Prescriptions, Researchers Argue

Nearly 4 out of 5 American neurologists prescribing multiple sclerosis (MS) drugs have received at least one payment from the pharmaceutical industry, a new study reports.

Those who prescribe larger amounts of MS drugs were more likely to have received payments, and those who got payments were more likely to prescribe the company’s d...

Ozempic, Zepbound Offer Unexpected Benefits For Psoriasis Patients

People with psoriasis might receive unexpected benefits from cutting-edge weight loss drugs like Ozempic and Zepbound, a new study says.

Psoriasis patients taking GLP-1 drugs had a 78% lower risk of premature death and a 44% lower risk of heart attack, stroke or other heart-related health crisis, researchers reported Thursday at a meeting ...

Shunts Safe And Effective For Rare Brain Condition In Elderly, Clinical Trial Concludes

A simple shunt can restore walking ability and independence in elderly people with a rare brain condition, a major new clinical trial has found.

Implanting a shunt to drain excess cerebrospinal fluid significantly improved walking and mobility among seniors with idiopathic normal pressure hydrocephalus (NPH), researchers reported Sept. 16 ...

Daily Aspirin Cuts Colon Cancer Recurrence Risk By Half

Aspirin can cut by more than half the risk that colon cancer will come back following initial treatment, a new clinical trial has found.

Daily aspirin reduced by 55% the risk of cancer recurrence in patients whose colorectal cancer is driven by a genetic mutation, researchers reported Sept. 17 in the New England Journal of Medicine